Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Silver Fern Farms in deal with world-leading biotech company

‘Silver Fern Farms in deal with world-leading biotech company’

Silver Fern Farms is moving up the value chain with the announcement of a long-term blood protein joint partnership with a world-leading biotechnology company.

The partnership to produce bovine blood plasma products is with US-based company Proliant Inc., an innovator in applied protein sciences for food, health and nutrition.

Proliant is the world’s leading producer of bovine serum albumin (BSA) which is used in the production of diagnostic/medical kit manufacturing, biopharmaceuticals, veterinary medicines, vaccines and antibodies, nutraceuticals and life-science research.

Keith Cooper, Silver Fern Farms’ Chief Executive, says the agreement fits with the company's strategy of creating value from co-products and with the company’s sustainability ethos.

"Proliant is an ideal partner, offering high technology, processing and global marketing expertise. A partnership of this nature, with the potential for additional multi-million dollar revenue to our co-operative over the tenure of the agreement will ensure that together we make the most of market opportunities and grow value from our products over the medium term.”

New Zealand currently produces around 1500 tonnes of blood plasma per annum of which 99 percent is exported for use in the manufacture of medical pharmaceuticals and nutritional products. The investment also aligns with the Ministry of Business Innovation & Employment’s Business Growth Agenda themes of encouraging innovation with clear links to export markets.

“This is a significant shift for our industry as annual production of blood plasma is predicted to grow six-fold over the next 5 years as a result of this agreement. We are also now dealing directly with the manufacturer through this partnership.

“To us this is exactly what the Government growth agenda is looking for – innovation which creates additional revenue,” says Keith Cooper.

Under the partnership new facilities to automate much of the closed-circuit capture of blood will be established at Silver Fern Farms’ meat processing plants in the North and South Islands.

Steve Welch, CEO of Proliant Inc. says the venture with Silver Fern Farms will give Proliant a reliable source of high-quality bovine blood plasma.

“Consistent supply of high-quality BSA is critical to the health care and medical research sector. People rely on the ready availability of pharmaceuticals, vaccines, nutraceuticals and diagnostic kits for their health, which is why we had to partner with the right people who understood our focus on excellence and reliability of delivery,” says Steve Welch.

Steve Welch says the partnership will be the start of a very long term relationship between the two companies.

“We chose Silver Fern Farms because of their strength in the beef industry. They have large available, quality supply, a long-term strategy of building brand equity, and a record of capital investment. Their new Te Aroha facility is impressive and demonstrates a clear commitment to the beef industry which will ensure our critical raw material long into the future.”

“New Zealand is a safe place to source bovine proteins as it has a negligible risk of BSE as well as other animal diseases of significance. It makes this country attractive for these kinds of long-term investments.

“We are a family-owned company and this partnership with a farmer-owned co-operative is also a good fit for us.”

Initial installations of the automated collection systems are planned for the Silver Fern Farms plants at Te Aroha on the North Island and Finegand on the South Island.

ENDS

Notes to Editors

About bovine serum albumin (BSA)

• Bovine blood forms the raw material from which the BSA is extracted. Large quantities of BSA can be readily purified from bovine blood - which is a co-product of the meat processing industry.

• BSA is useful in pharmaceutical processes because of its stability, its ability to increase signal in diagnostic assays and its lack of effect in many biochemical reactions.

• It is used in the production of diagnostic/medical device manufacturing, biopharmaceuticals, veterinary medicines, vaccines and antibodies, nutraceuticals and life-science research.

• Proliant Inc is the world’s largest and most experienced manufacturer of animal-derived proteins with over 50% of the BSA market.

About Silver Fern Farms:

- Silver Fern Farms is New Zealand’s leading processor and marketer of lamb, mutton, beef, venison and associated products to more than 60 countries.

- The company’s vision: Inspirational Food Created by Passionate People.

- Silver Fern Farms is a farmer-controlled co-operative representing more than 16,000 farmer shareholders.

- The company operates 23 processing facilities throughout the country, employing more than 7,000 staff in the peak of season.

- Key markets in North America, the United Kingdom and Europe, Asia and the Middle East are supported through a network of 8 international offices.

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Sky City : Auckland Convention Centre Cost Jumps By A Fifth

SkyCity Entertainment Group, the casino and hotel operator, is in talks with the government on how to fund the increased cost of as much as $130 million to build an international convention centre in downtown Auckland, with further gambling concessions ruled out. The Auckland-based company has increased its estimate to build the centre to between $470 million and $530 million as the construction boom across the country drives up building costs and design changes add to the bill.
More>>

ALSO:

RMTU: Mediation Between Lyttelton Port And Union Fails

The Rail and Maritime Union (RMTU) has opted to continue its overtime ban indefinitely after mediation with the Lyttelton Port of Christchurch (LPC) failed to progress collective bargaining. More>>

Earlier:

Science Policy: Callaghan, NSC Funding Knocked In Submissions

Callaghan Innovation, which was last year allocated a budget of $566 million over four years to dish out research and development grants, and the National Science Challenges attracted criticism in submissions on the government’s draft national statement of science investment, with science funding largely seen as too fragmented. More>>

ALSO:

Scoop Business: Spark, Voda And Telstra To Lay New Trans-Tasman Cable

Spark New Zealand and Vodafone, New Zealand’s two dominant telecommunications providers, in partnership with Australian provider Telstra, will spend US$70 million building a trans-Tasman submarine cable to bolster broadband traffic between the neighbouring countries and the rest of the world. More>>

ALSO:

More:

Statistics: Current Account Deficit Widens

New Zealand's annual current account deficit was $6.1 billion (2.6 percent of GDP) for the year ended September 2014. This compares with a deficit of $5.8 billion (2.5 percent of GDP) for the year ended June 2014. More>>

ALSO:

Still In The Red: NZ Govt Shunts Out Surplus To 2016

The New Zealand government has pushed out its targeted return to surplus for a year as falling dairy prices and a low inflation environment has kept a lid on its rising tax take, but is still dangling a possible tax cut in 2017, the next election year and promising to try and achieve the surplus pledge on which it campaigned for election in September. More>>

ALSO:

Job Insecurity: Time For Jobs That Count In The Meat Industry

“Meat Workers face it all”, says Graham Cooke, Meat Workers Union National Secretary. “Seasonal work, dangerous jobs, casual and zero hours contracts, and increasing pressure on workers to join non-union individual agreements. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news